Company intelligence / Profile preview

Glyciome LLC

Ownership: Private
Development stage: Preclinical

Overview

Glyciome has secured a patent for an affordable, user-friendly prebiotic personal lubricant designed to optimize vaginal ecosystem health and reduce vaginal imbalances associated with bacterial vaginosis, a risk factor for cervical cancer.

Therapeutic areas: Women's Health
Modalities: Prebiotic lubricants
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

PreBioGyn

Pre-clinical

Indications: Cervical cancer prevention

Partnerships

National Cancer InstituteHealth Sciences & Services Authority of Spokane County

Beyond the preview

Go deeper on Glyciome LLC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glyciome LLC.

Explore the full profile